M. Cyman et al. / Journal of Molecular Structure 1125 (2016) 558e569
567
0
0
4.2. Benzyl 3,4,6-tri-O-acetyl-2-deoxy-(2E)-hydroxyimino-
arabino- (3) -(2Z)-hydroxyimino- -arabino- (4) and -(2Z)-
hydroxyimino- -arabino-hexopyranosides (5)
b
-
D
-
6), 4.57 (d, 1 H, JA,B 11.5 Hz, CHBPh), 4.47 (dd, 1 H, J5,6 3.8 Hz, J6.6
a-D
11.95 Hz, H-60), 4.21 (m, 1 H, H-5), 2.02, 2.01, 1.96 (3 s, 9 H, 3 ꢀ OAc);
b
-D
13C NMR (CDCl3, 125 MHz):
d
170.8, 169.8, 169.7 (3 ꢀ C]O), 148.4
(C2), 136.1, 128.5, 127.9 (Carom), 96.1 (C1), 71.4 (C5), 69.1 (CH2), 67.0
8.06
3,4,6-Tri-O-acetyl-2-deoxy-2-nitroso-
ride (1) (0.34 g, 1 mmol) [37], benzyl alcohol (208
dry pyridine (161 L, 2 mmol) were dissolved in anhydrous THF
a-
D-glucopyranosyl chlo-
(C4), 63.9 (C6), 60.6 (C3), 20.9, 20.8, 20.6 (3 ꢀ COCH3); for 7:
d
mL, 2 mmol), and
(bs, 1 H, NOH), 7.27 (m, 5 H, Ph), 5.79 (s, 1 H, H-1), 5.73 (d, 1 H, J3.4
3.35 Hz, H-3), 5.39 (dd, 1 H, J3.4 3.4 Hz, J4.5 5.8 Hz, H-4), 4.87 (d, 1 H,
JA,B 11.5 Hz, CHAPh), 4.63 (d, 1 H, JA,B 11.5 Hz, CHBPh), 4.56 (dd, 1 H,
m
(7.5 mL). The reaction mixture was stirred and refluxed for 0.5 h.
The end of reaction was verified by TLC (solvent A). Then, the
mixture was evaporated, dissolved in CHCl3 (100 mL), washed
several times with H2O (20 mL), dried over Na2SO4, filtered off and
0
0
0
J5,6 8.7 Hz, J6.6 11.6 Hz, H-6), 4.41 (dd, 1 H, J5,6 4.75 Hz, J6.6 11.6 Hz,
H-60), 4.31 (m, 1 H, H-5), 2.02, 2.01, 2.00 (3 s, 9 H, 3 ꢀ OAc); 13C NMR
(CDCl3, 125 MHz):
d
170.7, 169.7, 169.8 (3 ꢀ C]O), 149.1 (C2), 136.8,
concentrated. The residue was chromatographed on silica gel
128.4, 127.8 (Carom), 91.1 (C1), 71.8 (C5), 70.6 (CH2), 67.3 (C3), 67.2
20
(solvent B) to afford first 3 (34.9 mg, 9%, syrup): [
a
]
ꢁ 8ꢂ (c 1.0,
(C4), 63.6 (C6), 20.9, 20.7 (3 ꢀ COCH3); MALDITOF-MS: m/z 432.2
D
CHCl3); Rf 0.48 (solvent A); IR:
n
3375 (OeH), 3032 (Bn CeH), 2932
(MþNa)þ, 448.1 (MþK)þ.
20
(CeH), 1749 (ester C]O), 1238 cmꢁ1 (ester CeO); 1H NMR (CDCl3,
500 MHz): 7.83 (s, 1 H, NOH), 7.37 (m, 5 H, Ph), 6.11 (d, 1 H, J3.4
Eluted second was 8 (519 mg, 42%, syrup): [
a
]
þ66.0ꢂ (c 1.0,
D
d
CHCl3); Rf 0.35 (solvent A); IR: n 3354 (OeH), 3031 (Bn CeH), 2932
7.4 Hz, H-3), 5.68 (dd,1 H, J3.4 7.55 Hz, J4.5 8.8 Hz H-4), 5.22 (s,1 H, H-
1), 4.91 (d, 1 H, JA,B 12.2 Hz, CHAPh), 4.67 (d, 1 H, JA,B 12.05 Hz
(CeH), 1750 (ester C]O), 1230 cmꢁ1 (ester CeO); 1H NMR (CDCl3,
500 MHz): 8.76 (bs, 1 H, NOH), 7.35 (m, 5 H, Ph), 6.13 (s, 1 H, H-1),
d
0
0
CHBPh), 4.35 (dd, 1 H, J5.6 4.7 Hz, J6.6 12.1 Hz, H-6), 4.24 (dd, 1 H, J5,6
5.89 (d,1 H, J3.4 3.4 Hz, H-3), 5.50 (d,1 H, J3.4 3.2 Hz H-4), 4.76 (d,1 H,
JA,B 11.75 Hz, CHAPh), 4.65 (d, 1 H, JA,B 11.75 Hz, CHBPh), 4.43 (t, 1 H,
3.45 Hz, J6.6 12.05 Hz, H-60), 3.97 (m, 1 H, H-5), 2.04 (s, 6 H, 2 ꢀ
0
OAc), 2.01 (s, 3 H, OAc); 13C NMR (CDCl3, 125 MHz):
d
170.7, 169.7,
J5.6 6.6 Hz, J5.6 6.55 Hz H-5), 4.09 (d, 1 H, J5.6 6.6 Hz, H-6), 4.08 (d,
0
1 H, J5.6 6.55 Hz, H-60), 2.13 (s, 3 H, OAc), 2.08 (s, 3 H, OAc), 2.07 (s,
0
169.6 (3 ꢀ C]O), 149.4 (C2), 136.8, 128.5, 127.9, 127.7 (Carom), 95.7
(C1), 71.8 (C5) 69.1 (CH2), 68.1 (C4), 63.7 (C3), 63.1 (C6), 20.72, 20.7,
20.5 (3 ꢀ COCH3); MALDI-TOF-MS: m/z 432.2 (MþNa)þ 448.1
3 H, OAc); 13C NMR (CDCl3, 125 MHz):
d
170.4, 170.3, 169.4 (3 ꢀ C]
O), 147.7 (C2), 136.4, 128.5, 128.2, 128.1 (Carom), 89.7 (C1), 70.1 (CH2),
69.1 (C4), 67.1 (C5), 66.9 (C3), 61.7 (C6), 20.7, 20.6, 20.4 (3 ꢀ
COCH3); MALDITOF-MS: m/z 432.2 (MþNa)þ, 448.1 (MþK)þ.
(MþK)þ.
20
Eluted second was 4 (188.9 mg, 46%, syrup): [
a]
þ81ꢂ (c 1.0,
D
CHCl3); Rf 0.42 (solvent A); IR: n 3375 (OeH), 3032 (Bn CeH), 2930
(CeH), 1754 (ester C]O), 1230 cmꢁ1 (ester CeO); 1H NMR (CDCl3,
500 MHz): 8.11 (s, 1 H, NOH), 7.35 (m, 5 H, Ph), 6.08 (s, 1 H, H-1),
4.4. General procedure for O-deacetylation
d
5.81 (d, 1 H, J3.4 9.65 Hz, H-3), 5.20 (t, 1 H, J3,4 9.65 Hz, J4.5 9.8 Hz, H-
4), 4.74 (d, 1 H, JA,B 11.85 Hz, CHAPh), 4.67 (d, 1 H, JA,B 11.85 Hz,
The mixture of 3, 4, or 7 (40.9 mg, 0.1 mmol) and 0.1 M solution
of MeONa in MeOH (0.6 mL, 0.06 mmol) was stirred at rt for 0.5 h.
The end of reaction was verified with TLC (solvent C). Then, it was
treated with Dowex Hþ 50WX4-400, filtered and concentrated.
0
CHBPh), 4.28 (dd, 1 H, J5,6 4.4 Hz, J6.6 12.35 Hz, H-6), 4.19 (ddd, 1 H,
0
0
0
J4,5 10.1 Hz, J5.6 4.4 Hz, J5.6 2.2 Hz H-5), 4.02 (dd, 1 H, J5.6 2.4 Hz, J6.6
12.3 Hz H-60), 2.08 (s, 3 H, OAc), 2.06 (s, 3 H, OAc), 2.04 (s, 3 H, OAc);
13C NMR (CDCl3, 125 MHz):
d
170.7, 169.7, 169.3 (3 ꢀ C]O), 148.9
4.4.1. Benzyl 2-deoxy-(2E)-hydroxyimino-b-D-arabino-
hexopyranoside (9)
(C2), 136.4, 128.5, 128.2, 128.1 (Carom), 89.8 (C1), 70.2 (CH2), 69.5
(C3), 69.3 (C4), 68.0 (C5), 61.8 (C6), 20.7, 20.6, 20.5 (3 ꢀ COCH3);
MALDI-TOF-MS: m/z 432.2 (MþNa)þ, 448.1 (MþK)þ.
Deacetylation of 3 (51.1 mg, 0.12 mmol) gave 9 (35.3 mg, 99%,
mp 150e151 ꢂC): [
a]
20 ꢁ 23.0 (c 0.8, CH3OH); Rf 0.8 (solvent C); IR:
n
D
Eluted third was 5 (32.9 mg, 8%, syrup): Rf 0.39 (solvent A); IR:
n
3462, 3359 (OeH), 3074 (Bn CeH), 2919 (CeH), 1628 (C]N); 1H
3344 (OeH), 2958, 2928 (CeH), 1747 (ester C]O), 1658 (C]N),
NMR (CD3OD, 500 MHz): d 7.35 (m, 5 H, Ph), 5.14 (s, 1 H, H-1), 4.86
(d, 1 H, JA,B 11.75 Hz, CHAPh), 4.63 (d, 1 H, JA,B 11.75 Hz, CHBPh), 4.57
1230 cmꢁ1 (ester CeO); 1H NMR (CDCl3, 500 MHz):
d
8.12 (s, 1 H,
NOH), 7.34 (m, 5 H, Ph), 5.88 (s, 1 H, H-1), 5.52 (d, 1 H, J3.4 5.5 Hz, H-
3), 5.31 (t, 1 H, J3,4 5.5 Hz J4.5 5.5 Hz, H-4), 4.91 (d, 1 H, JA,B 12.2 Hz,
CHAPh), 4.69 (d, 1 H, JA,B 12.2 Hz, CHBPh), 4.43 (d, 2 H, J5,6 6.1 Hz, 2 ꢀ
H-6), 4.03 (q, 1 H, J4,5 5.85 Hz, J5.6 6.4 Hz, H-5), 2.08 (s, 3 H, OAc),
2.08 (s, 3 H, OAc), 2.07 (s, 3 H, OAc); 13C NMR (CDCl3, 125 MHz):
(d, 1 H, J3.4 8.2 Hz, H-3), 4.21 (dd, 1 H, J3.4 8.6 Hz, J4.5 9.4 Hz, H-4),
3.87 (dd, 1 H, J6.6 11.7 Hz, J5.6 2.8 Hz H-60), 3.75 (dd, 1 H, J5.6 5.6 Hz,
0
0
0
0
J6.6 11.7 Hz, H-6), 3.49 (ddd, 1 H, J4.5 9.4 Hz, J5.6 5.6 Hz, J5.6 2.8 Hz, H-
5); 13C NMR (CD3OD,125 MHz):
d
153.1 (C2),137.7,127.9,127.7,127.2
(Carom), 96.7 (C1), 76.8 (C5), 68.5 (CH2), 68.4 (C4), 67.3 (C3), 62.6
(C6); MALDITOF-MS: m/z 284.3 (MþH)þ, 306.1 (MþNa)þ, 322.1
(MþK)þ.
d
170.6, 169.5, 169.4 (3 ꢀ C]O), 149.1 (C2), 136.7, 128.4, 128.0, 127.0
(Carom), 90.2 (C1), 72.6 (C5), 70.6 (CH2), 68.3 (C4), 68.1 (C3), 64.0
(C6), 20.84, 20.79 (3
ꢀ
COCH3); MALDITOF-MS: m/z 432.2
(MþNa)þ, 448.2 (MþK)þ.
4.4.2. Benzyl 2-deoxy-(2E)-hydroxyimino-
a-D-arabino- (10) and
-(2Z)-hydroxyimino- -arabino-hexopyranosides (11)
a-D
4.3. Benzyl 3,4,6-tri-O-acetyl-2-deoxy-(2E)-hydroxyimino-
lyxo- (6), -(2Z)-hydroxyimino- -lyxo- (7) and -(2Z)-
hydroxyimino- -lyxo-hexopyranosides (8)
b
-D-
Deacetylation of 4 (211.3 mg, 0.5 mmol) gave a mixture of two
products, which was chromatographed (solvent D) yielded first 10
b-D
a-D
(33.3 mg, 23%, syrup): Rf 0.8 (solvent C); IR:
n
3388, 3252 (OeH),
7.35
2927, 2878 (CeH), 1640 (C]N); 1H NMR (CD3OD, 500 MHz):
d
These were synthesized analogously to 3e5 using 3,4,6-tri-O-
acetyl-2-deoxy-2-nitroso- -galactopyranosyl chloride (2) (1 g,
3 mmol) [37], benzyl alcohol (615 L, 6 mmol), pyridine (0.5 mL,
(m, 5 H, Ph), 6.16 (s, 1 H, H-1), 5.04 (d, 1 H, J3.4 9.45 Hz, H-3), 4.81 (d,
1 H, JA,B 11.5 Hz, CHAPh), 4.65 (d, 1 H, JA,B 11.8 Hz, CHBPh), 3.88 (m,
a-D
m
1 H, H-5), 3.74 (m, 1 H, H-4); 13C NMR (CD3OD, 125 MHz):
d; 137.3,
6 mmol) and THF (22.5 mL). Column chromatography (solvent B)
gave first a mixture of 6 and 7 (131.3 mg 11%, syrup): Rf 0.40 (sol-
127.9, 127.7, 127.5 (Carom), 90.3 (C1), 82.2 (C3), 72.9 (C5), 69.7 (C4),
68.9 (CH2), 60.9 (C6); MALDITOF-MS: m/z 306.1 (MþNa)þ, 322.1
(MþK)þ.
vent A); IR:
C]O), 1230 cmꢁ1 (ester CeO); 1H NMR (CDCl3, 500 MHz) for 6:
8.06 (bs, 1 H, NOH), 7.27 (m, 5 H, Ph), 6.32 (d, 1 H, J3.4 3.9 Hz, H-3),
n 3398 (OeH), 3030 (Bn CeH), 2937 (CeH), 1749 (ester
Eluted second was 11 (69 mg, 47%, mp 108 ꢂC): [
a
]
D
20 þ131.8ꢂ (c 1,
d
CH3OH); Rf 0.64 (solvent C); IR:
1641 (C]N); 1H NMR (CD3OD, 500 MHz):
1 H, H-1), 4.80 (d,1H, JA,B 11.75 Hz, CHAPh), 4.63 (d,1 H, JA,B 11.75 Hz,
n 3388, 3244 (OeH), 2928 (CeH),
5.19 (s, 1 H, H-1), 5.17 (t, 1 H, J3.4 4.3 Hz, J4.5 4.65 Hz, H-4), 4.85 (d,
d 7.35 (m, 5 H, Ph), 6.10 (s,
0
1 H, JA,B 11.5 Hz, CHAPh), 4.69 (dd, 1 H, J5,6 8.75 Hz, J6.6 11.95 Hz, H-